NJTC Venture Fund Select Portfolio Investments March 2014 Agenda - - PowerPoint PPT Presentation

▶
njtc venture fund
SMART_READER_LITE
LIVE PREVIEW

NJTC Venture Fund Select Portfolio Investments March 2014 Agenda - - PowerPoint PPT Presentation

Mar 22, 2024 354 likes •453 views

NJTC Venture Fund Select Portfolio Investments March 2014 Agenda NJTC Venture Fund Profile Representative Investments seek partners CytoSorbents IntraCellular Therapies IntegriChain InstaMed Amber Road

slide-1
SLIDE 1

NJTC Venture Fund

Select Portfolio Investments March 2014

slide-2
SLIDE 2

Agenda

  • NJTC Venture Fund Profile
  • Representative Investments – seek

partners

– CytoSorbents – IntraCellular Therapies – IntegriChain – InstaMed – Amber Road

  • Woomera Partners – Acquisition Criteria
slide-3
SLIDE 3

NJTC Venture Fund

  • $80 million regional venture investor
  • No new investments
  • Latter stage of fund life
  • Seek partner and ultimately exit
  • pportunities for portfolio
slide-4
SLIDE 4

CytoSorbents (www.cytosorbents.com)

  • Extra-corporal blood filter – broad medical applicability

– Cardio pulmonary bypass – Sepsis – Blood transfusion – Drug absorption in case of overdose – Contrast agents for chemotherapy and imaging – Pancreatitis, burn, trauma

  • $2.4 million revenue in 2013 following CE Mark
  • 30 investigator-led trials (unsponsored by company) in

Europe

  • Seek partner to co-develop each indication
slide-5
SLIDE 5

IntraCellular Therapies (www.IntraCellularTherapies.com)

  • Biotech developer of central nervous system

therapeutics

– Schizophrenia, Depression, Bi-polar – Parkinsons, Dementia, Autism

  • Nobel Laureate co-founder
  • Deep pipeline at phase I, II, III or pre-clinical
  • Compelling recent success of phase II

schizophrenia compound

  • Seek corporate partner to co-develop assets
slide-6
SLIDE 6

IntegriChain (www.IntegriChain.com)

  • Provider of cloud-based data analytics to drug

industry

  • Customers include two-thirds of largest big

pharma and biotech

  • Product applicable to other industries with

complex supply chain

– Consumer packaged goods, Books & Publishing, Retail, Food & Beverage

  • Seek partners for further expansion into

healthcare plus growth in non Life Sciences

slide-7
SLIDE 7

InstaMed (www.InstaMed.com)

  • Software platform accelerates collection of

provider payments

  • Processed billions of dollars in claims and

remittances in 2013

  • Expanding network of payors, health IT

vendors and financial institutions

slide-8
SLIDE 8

Amber Road (www.AmberRoad.com)

  • SaaS global trade software applications
  • Customers include GE, Monsanto,

Walmart

  • Geographic penetration

– S Africa – Asia – Europe

Source: WTO Statistics, 2013

slide-9
SLIDE 9

Woomera Partners (www.WoomeraPartners.com)

  • Recently launched to acquire health

technology and health services companies

  • $50 million revenue ideal – target ranges

from $20 million - $70 million

  • Corporate divestitures, independently
  • wned, VC or PE backed